Blood Cancer Research WA

Blood Cancer Research WA is a Western Australia-based nonprofit clinical research organization focused on expanding patient access to novel therapies and clinical trials for blood cancers. The organization supports and delivers clinical research programs for patients with leukaemia, lymphoma, and myeloma, with a particular emphasis on getting Western Australian patients access to potentially life-saving treatments closer to home. It appears to function primarily as a trial-enablement and translational research charity rather than as a traditional drug-discovery biotech with a proprietary therapeutic pipeline. Publicly available information highlights work in advanced therapeutics including cellular therapies, bispecific antibodies, and small-molecule inhibitors, and leadership by lymphoma specialist Professor Chan Cheah. The group was established through earlier support from the Snowdome Foundation and has operated as an independent not-for-profit organization since January 1, 2023.